FEops HEARTguide vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
FEops HEARTguide
by FEops
VS
ASSURE Wearable ECG
by Kestra Medical Technologies

AI Verdict

These tools address different phases of cardiac patient care. FEops HEARTguide is designed for pre-operative planning and optimization of structural heart procedures through predictive simulations, while ASSURE Wearable ECG focuses on continuous heart rate monitoring and data collection for at-risk cardiac patients. Therefore, they are not direct competitors but rather complementary solutions within cardiology.

Choose FEops HEARTguide if…

Choose FEops HEARTguide if your primary need is advanced pre-operative planning for structural heart procedures. This tool is ideal for cardiologists and cardiothoracic surgeons who require patient-specific predictive simulations and precise anatomical measurements to optimize device sizing and positioning before intervention, aiming to improve patient outcomes. It helps in evaluating potential outcomes and minimizing risks associated with complex structural heart disease treatments.

View FEops HEARTguide →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you need continuous, long-term heart rate monitoring and data collection for at-risk cardiac patients in an outpatient setting. This wearable device is best suited for clinicians seeking to remotely track patient cardiac activity, detect episodes automatically, and receive alert-based notifications, providing valuable insights into patient trends outside of the hospital. It offers a non-invasive solution for ongoing cardiac surveillance and early detection of anomalies.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FEops HEARTguide ASSURE Wearable ECG
Deployment Cloud Based platform The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FEops HEARTguide ASSURE Wearable ECG
Name FEops HEARTguide ASSURE Wearable ECG
Primary Function Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning. Non-therapeutic device for continuous heart rate monitoring and data collection, integrated into a digital healthcare platform for at-risk cardiac patients.
Company FEops NV Kestra Medical Technologies
Core Technology / Monitoring Predictive simulation technology, AI-based anatomical measurements, Digital twin technology for patient-specific replicas. Wearable ECG device for continuous heart rate monitoring, ASSURE Detection Algorithm with Quad Channel Processing, Adaptive Patient Intelligence for filtering motion artifacts.
Data Input / Sensors DICOM interface for CT scan upload. SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors.
Clinician Interface / Data Access Cloud-based platform with anytime, anywhere access, Interactive 2D and 3D viewer, Evaluation of device sizing and positioning pre-operatively. Kestra CareStation remote patient data platform for clinician review, Automatic episode storage, Alert-based notifications, Physiologic trend data.
Categories Cardiology AI, Surgical AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguide and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FEops HEARTguide is designed for pre-operative planning of structural heart procedures, utilizing predictive simulations and anatomical measurements to optimize device sizing and positioning. In contrast, the ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection in at-risk cardiac patients, often used after a Wearable Cardioverter Defibrillator (WCD) prescription.
FEops HEARTguide acquires patient data by utilizing a DICOM interface for CT scan uploads, which are then used to create digital twins for predictive simulations. The ASSURE Wearable ECG collects data through a wearable ECG device with non-adhesive, embedded sensors in a SensorFit Garment, continuously monitoring heart rhythms.
FEops HEARTguide leverages a cloud-based AI and digital twin platform to provide predictive simulations and AI-based anatomical measurements for structural heart procedure planning. The ASSURE Wearable ECG utilizes the ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence to filter motion artifacts and analyze heart rhythms.
FEops HEARTguide is best suited for patients undergoing structural heart procedures, such as transcatheter aortic valve implantation (TAVI) and left atrial appendage occlusion (LAAO), to optimize pre-operative planning. The ASSURE Wearable ECG is intended for adult patients who were previously prescribed the ASSURE WCD system and may be asymptomatic or suffer from transient cardiac symptoms, requiring continuous heart rate monitoring.
FEops HEARTguide primarily focuses on pre-operative planning and simulation, with a collaborative cloud platform for sharing cases. In contrast, the ASSURE Wearable ECG includes the Kestra CareStation remote patient data platform for clinician review of physiologic trend data and automatic episode storage, along with alert-based notifications.
FEops HEARTguide provides interactive 2D and 3D viewers, semi-automatic identification and measurement of anatomical landmarks, and predictive simulations for evaluating device sizing and positioning pre-operatively. The ASSURE Wearable ECG offers automatic episode storage, alert-based notifications, and physiologic trend data, with Adaptive Patient Intelligence specifically designed to filter motion artifacts for accurate heart rate monitoring.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring FEops HEARTguide or ASSURE Wearable ECG

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.